Peer Review reports
From: Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
Original Submission | ||
---|---|---|
20 Sep 2009 | Submitted | Original manuscript |
20 Sep 2009 | Author responded | Author comments - Da-zhi Xu |
Resubmission - Version 2 | ||
20 Sep 2009 | Submitted | Manuscript version 2 |
20 Sep 2009 | Author responded | Author comments - Da-zhi Xu |
14 Nov 2009 | Reviewed | Reviewer Report - Volker Wacheck |
23 Nov 2009 | Reviewed | Reviewer Report - Leri Faried |
11 May 2010 | Reviewed | Reviewer Report - Brian Egleston |
Resubmission - Version 3 | ||
20 Sep 2009 | Submitted | Manuscript version 3 |
29 May 2010 | Author responded | Author comments - Da-zhi Xu |
Resubmission - Version 4 | ||
29 May 2010 | Submitted | Manuscript version 4 |
22 Jun 2010 | Reviewed | Reviewer Report - Brian Egleston |
30 Jun 2010 | Reviewed | Reviewer Report - Leri Faried |
13 Jul 2010 | Reviewed | Reviewer Report - Volker Wacheck |
23 Aug 2010 | Author responded | Author comments - Da-zhi Xu |
Resubmission - Version 5 | ||
23 Aug 2010 | Submitted | Manuscript version 5 |
6 Sep 2010 | Reviewed | Reviewer Report - Volker Wacheck |
2 Oct 2010 | Author responded | Author comments - Da-zhi Xu |
Resubmission - Version 6 | ||
2 Oct 2010 | Submitted | Manuscript version 6 |
Publishing | ||
7 Oct 2010 | Editorially accepted | |
7 Oct 2010 | Article published | 10.1186/1471-2407-10-536 |
You can find further information about peer review here.